scholarly article | Q13442814 |
P50 | author | Urs A. Meyer | Q14623733 |
P2093 | author name string | Joram Feldon | |
Benjamin K Yee | |||
Manfred Schedlowski | |||
P433 | issue | 4 | |
P921 | main subject | immunology | Q101929 |
P304 | page(s) | 378-388 | |
P577 | publication date | 2005-12-27 | |
P1433 | published in | Brain, Behavior, and Immunity | Q15716593 |
P1476 | title | Immunological stress at the maternal-foetal interface: a link between neurodevelopment and adult psychopathology. | |
P478 | volume | 20 |
Q35700368 | A lifespan approach to neuroinflammatory and cognitive disorders: a critical role for glia |
Q37137212 | A review of the fetal brain cytokine imbalance hypothesis of schizophrenia. |
Q42736872 | Aberrant NF-kappaB expression in autism spectrum condition: a mechanism for neuroinflammation |
Q30444600 | Aberrant neural synchrony in the maternal immune activation model: using translatable measures to explore targeted interventions |
Q30484249 | Activation of the maternal immune system alters cerebellar development in the offspring |
Q42248543 | Activation of the maternal immune system during pregnancy alters behavioral development of rhesus monkey offspring. |
Q58115944 | Adverse neuropsychiatric development following perinatal brain injury: from a preclinical perspective |
Q37310541 | Animal Models of Maternal Immune Activation in Depression Research |
Q58207334 | Animal models may help fractionate shared and discrete pathways underpinning schizophrenia and autism |
Q30445744 | Animal models of prenatal immune challenge and their contribution to the study of schizophrenia: a systematic review. |
Q88677803 | Association of Maternal Exposure to Childhood Abuse With Elevated Risk for Attention Deficit Hyperactivity Disorder in Offspring |
Q30389278 | Behavioral alterations in rat offspring following maternal immune activation and ELR-CXC chemokine receptor antagonism during pregnancy: implications for neurodevelopmental psychiatric disorders |
Q41611297 | Bridging Autism Spectrum Disorders and Schizophrenia through inflammation and biomarkers - pre-clinical and clinical investigations |
Q47899520 | Chorioamnionitis, IL-17A, and fetal origins of neurologic disease |
Q40139863 | Clinical chorioamnionitis at term V: umbilical cord plasma cytokine profile in the context of a systemic maternal inflammatory response |
Q30474963 | Contribution of nonprimate animal models in understanding the etiology of schizophrenia |
Q37232855 | Cytokines and the neurodevelopmental basis of mental illness |
Q92008483 | Developmental dysfunction of prefrontal-hippocampal networks in mouse models of mental illness |
Q51662537 | Developmental immunotoxicology (DIT): windows of vulnerability, immune dysfunction and safety assessment. |
Q34426190 | Developmental programming of brain and behavior by perinatal diet: focus on inflammatory mechanisms |
Q38686115 | Disrupted Circadian Rhythm as a Common Player in Developmental Models of Neuropsychiatric Disorders. |
Q51998836 | Disruption of the US pre-exposure effect and latent inhibition in two-way active avoidance by systemic amphetamine in C57BL/6 mice. |
Q36986370 | Does Systemic Inflammation Play a Role in Pediatric Psychosis? |
Q37272268 | Dopamine and serotonin levels following prenatal viral infection in mouse--implications for psychiatric disorders such as schizophrenia and autism |
Q30487006 | Early-life programming of later-life brain and behavior: a critical role for the immune system |
Q57212660 | Effects of Panax ginseng C.A. Meyer extract on the offspring of adult mice with maternal immune activation |
Q37765634 | Effects of exogenous agents on brain development: stress, abuse and therapeutic compounds. |
Q36999907 | Effects of prenatal Poly I:C exposure on global histone deacetylase (HDAC) and DNA methyltransferase (DNMT) activity in the mouse brain |
Q36986300 | Encephalization, emergent properties, and psychiatry: a minicolumnar perspective |
Q47560020 | Enhanced Th17 phenotype in uninfected neonates born from viremic HIV-1-infected pregnant women |
Q88047545 | Environmental Mechanisms of Neurodevelopmental Toxicity |
Q57403291 | Environmental Risk Factors for Schizophrenia |
Q33718930 | Evolution of structural abnormalities in the rat brain following in utero exposure to maternal immune activation: A longitudinal in vivo MRI study |
Q35786658 | Experimental Malaria in Pregnancy Induces Neurocognitive Injury in Uninfected Offspring via a C5a-C5a Receptor Dependent Pathway |
Q36888123 | Frank A. Beach award: programming of neuroendocrine function by early-life experience: a critical role for the immune system |
Q33828632 | Frontal-subcortical protein expression following prenatal exposure to maternal inflammation. |
Q47555789 | Functional Connectivity Alterations between Networks and Associations with Infant Immune Health within Networks in HIV Infected Children on Early Treatment: A Study at 7 Years |
Q54280525 | Gene expression analysis reveals schizophrenia-associated dysregulation of immune pathways in peripheral blood mononuclear cells. |
Q28067507 | Gene × Environment Interactions in Schizophrenia: Evidence from Genetic Mouse Models |
Q48467010 | Hypoactivity of the central dopaminergic system and autistic-like behavior induced by a single early prenatal exposure to lipopolysaccharide. |
Q37707129 | IL-1 receptor blockade prevents fetal cortical brain injury but not preterm birth in a mouse model of inflammation-induced preterm birth and perinatal brain injury |
Q28275427 | Immunologic and neurodevelopmental susceptibilities of autism |
Q100693867 | Increased RNA editing in maternal immune activation model of neurodevelopmental disease |
Q34297349 | Interleukin-1 receptor blockade in perinatal brain injury |
Q30495627 | Interleukin-10/Ceftriaxone prevents E. coli-induced delays in sensorimotor task learning and spatial memory in neonatal and adult Sprague-Dawley rats |
Q46728971 | Late N-acetylcysteine treatment prevents the deficits induced in the offspring of dams exposed to an immune stress during gestation |
Q34660546 | Late Prenatal Immune Activation in Mice Leads to Behavioral and Neurochemical Abnormalities Relevant to the Negative Symptoms of Schizophrenia |
Q37695333 | Lifetime Modulation of the Pain System via Neuroimmune and Neuroendocrine Interactions. |
Q35719523 | Lipopolysaccharide Exposure Induces Maternal Hypozincemia, and Prenatal Zinc Treatment Prevents Autistic-Like Behaviors and Disturbances in the Striatal Dopaminergic and mTOR Systems of Offspring |
Q39162211 | Long-term altered immune responses following fetal priming in a non-human primate model of maternal immune activation |
Q37242518 | Low level methylmercury enhances CNTF-evoked STAT3 signaling and glial differentiation in cultured cortical progenitor cells |
Q47932843 | Maternal CD8+ T-cell depletion alleviates intrauterine inflammation-induced perinatal brain injury |
Q99238275 | Maternal Immune Activation Affects Hippocampal Excitatory and Inhibitory Synaptic Transmission in Offspring From an Early Developmental Period to Adulthood |
Q30377656 | Maternal Immune Activation Disrupts Dopamine System in the Offspring |
Q30238718 | Maternal Immune Activation and Autism Spectrum Disorder: From Rodents to Nonhuman and Human Primates |
Q33633446 | Maternal Inflammation, Fetal Brain Implications and Suggested Neuroprotection: A Summary of 10 Years of Research in Animal Models |
Q64116157 | Maternal Supplementation of Low Dose Fluoride Alleviates Adverse Perinatal Outcomes Following Exposure to Intrauterine Inflammation |
Q36146434 | Maternal immune activation by poly I:C induces expression of cytokines IL-1β and IL-13, chemokine MCP-1 and colony stimulating factor VEGF in fetal mouse brain |
Q30435550 | Maternal immune activation causes age- and region-specific changes in brain cytokines in offspring throughout development |
Q42149384 | Maternal immune activation produces cerebellar hyperplasia and alterations in motor and social behaviors in male and female mice |
Q91314954 | Maternal immune activation: reporting guidelines to improve the rigor, reproducibility, and transparency of the model |
Q90733134 | Microglia activation in the offspring of prenatal Poly I: C exposed rats: a PET imaging and immunohistochemistry study |
Q30457462 | Models of neurodevelopmental abnormalities in schizophrenia |
Q36818391 | Neonatal binge alcohol exposure increases microglial activation in the developing rat hippocampus |
Q44990155 | Neonatal immune challenge alters reproductive development in the female rat. |
Q34159072 | Neonatal stress-induced affective changes in adolescent Wistar rats: early signs of schizophrenia-like behavior. |
Q35131870 | Neurodevelopmental and environmental hypotheses of negative symptoms of schizophrenia |
Q30405077 | Oligodendroglial alterations and the role of microglia in white matter injury: relevance to schizophrenia |
Q48013438 | P2X7 receptor blockade prevents preterm birth and perinatal brain injury in a mouse model of intrauterine inflammation |
Q41183411 | Peripheral Blood Leukocyte Production of BDNF following Mitogen Stimulation in Early Onset and Regressive Autism |
Q54201255 | Pioglitazone abolishes autistic-like behaviors via the IL-6 pathway. |
Q34280525 | Prenatal and perinatal risk factors for autism in China |
Q38021432 | Prenatal and postnatal animal models of immune activation: relevance to a range of neurodevelopmental disorders |
Q48609673 | Prenatal and postnatal maternal contributions in the infection model of schizophrenia. |
Q37412403 | Prenatal exposure to infection: a primary mechanism for abnormal dopaminergic development in schizophrenia |
Q44812893 | Prenatal immune activation leads to multiple changes in basal neurotransmitter levels in the adult brain: implications for brain disorders of neurodevelopmental origin such as schizophrenia |
Q27304814 | Prenatal immune challenge in rats: effects of polyinosinic-polycytidylic acid on spatial learning, prepulse inhibition, conditioned fear, and responses to MK-801 and amphetamine. |
Q30488086 | Prenatal immune challenge is an environmental risk factor for brain and behavior change relevant to schizophrenia: evidence from MRI in a mouse model |
Q30470115 | Prenatal stress: role in psychotic and depressive diseases |
Q64103670 | Rational use of mesenchymal stem cells in the treatment of autism spectrum disorders |
Q41072635 | Regulation of Toll-like receptors in the choroid plexus in the immature brain after systemic inflammatory stimuli |
Q48405002 | Relative prenatal and postnatal maternal contributions to schizophrenia-related neurochemical dysfunction after in utero immune challenge |
Q30416883 | Schizophrenia and Depression Co-Morbidity: What We have Learned from Animal Models |
Q34570990 | Schizophrenia and neural tube defects: comparisons from an epidemiological perspective |
Q47560487 | Sex Differences in Early Postnatal Microglial Colonization of the Developing Rat Hippocampus Following a Single-Day Alcohol Exposure. |
Q30459901 | Sex effects on neurodevelopmental outcomes of innate immune activation during prenatal and neonatal life |
Q91890631 | Sex-Dependent Effects of Perinatal Inflammation on the Brain: Implication for Neuro-Psychiatric Disorders |
Q48091285 | Spirulina diet to lactating mothers protects the antioxidant system and reduces inflammation in post-natal brain after systemic inflammation |
Q30234571 | Systematic assessment of environmental risk factors for bipolar disorder: an umbrella review of systematic reviews and meta-analyses |
Q92511410 | The Anti-inflammatory Compound Candesartan Cilexetil Improves Neurological Outcomes in a Mouse Model of Neonatal Hypoxia |
Q93219501 | The Effect of Intrauterine Inflammation on mTOR signaling in Mouse Fetal Brain |
Q28067530 | The Indispensable Roles of Microglia and Astrocytes during Brain Development |
Q30501563 | The International Society for Developmental Psychobiology annual meeting symposium: Impact of early life experiences on brain and behavioral development |
Q30449556 | The immune system and developmental programming of brain and behavior |
Q39015394 | The immune system as a novel regulator of sex differences in brain and behavioral development. |
Q37057724 | The influence of maternal prenatal and early childhood nutrition and maternal prenatal stress on offspring immune system development and neurodevelopmental disorders |
Q27331695 | The interaction between maternal immune activation and alpha 7 nicotinic acetylcholine receptor in regulating behaviors in the offspring |
Q28303485 | The neurodevelopmental impact of prenatal infections at different times of pregnancy: the earlier the worse? |
Q30470162 | The nuclear factor-κB inhibitor pyrrolidine dithiocarbamate reduces polyinosinic-polycytidilic acid-induced immune response in pregnant rats and the behavioral defects of their adult offspring |
Q48448425 | The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology. |
Q40737834 | Transgenerational transmission and modification of pathological traits induced by prenatal immune activation |
Q50461350 | Tumour necrosis factor-mediated homeostatic synaptic plasticity in behavioural models: testing a role in maternal immune activation. |
Q44094269 | Using experimental autoimmune encephalomyelitis as a model to study the effect of prenatal stress on fetal programming |
Q57464787 | Variability in PolyIC induced immune response: Implications for preclinical maternal immune activation models |
Q30440507 | Viral infection, inflammation and schizophrenia |
Q30492006 | Viral regulation of aquaporin 4, connexin 43, microcephalin and nucleolin |
Search more.